VolitionRX Limited (VNRX): Price and Financial Metrics
VNRX Price/Volume Stats
| Current price | $0.62 | 52-week high | $2.10 |
| Prev. close | $0.62 | 52-week low | $0.55 |
| Day low | $0.57 | Volume | 245,813 |
| Day high | $0.65 | Avg. volume | 177,447 |
| 50-day MA | $0.88 | Dividend yield | N/A |
| 200-day MA | $0.96 | Market Cap | 50.55M |
VNRX Stock Price Chart Interactive Chart >
VolitionRX Limited (VNRX) Company Bio
VolitionRX Limited, a clinical-stage life sciences company, focuses on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The company is based in Singapore.
Latest VNRX News From Around the Web
Below are the latest news stories about VOLITIONRX LTD that investors may wish to consider to help them evaluate VNRX as an investment opportunity.
Sidoti Events, LLC's Virtual December Small-Cap ConferenceNEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December ... |
VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie EntreprendreVolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has closed on an aggregate of Euro 5.0 million (approximately $5.5 million) in financing from Wallonie Entreprendre S.A. ("WE") in Belgium. |
VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call TranscriptVolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript November 15, 2023 Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited Third Quarter 2023 Earnings Conference Call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be opened for questions. [Operator […] |
VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business UpdateVolitionRx Limited (NYSE American: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended September 30, 2023. Volition management will host a conference call tomorrow, November 15 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below. |
VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business UpdateVolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Wednesday, November 15 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter 2023, in addition to providing a business update. Details of this event can also be found below. |
VNRX Price Returns
| 1-mo | -22.50% |
| 3-mo | -37.55% |
| 6-mo | -20.23% |
| 1-year | -63.53% |
| 3-year | -80.38% |
| 5-year | -81.71% |
| YTD | -13.53% |
| 2023 | -70.49% |
| 2022 | -22.61% |
| 2021 | -19.28% |
| 2020 | -17.93% |
| 2019 | 161.88% |
Loading social stream, please wait...